28bio Launches CNS-3D Plasticity Organoids to Assess Drug Effects on Human Learning and Memory

Cognitive biomarker assays inform safety and efficacy decisions by measuring network potentiation and synaptic plasticity Advances the emerging field of organoid intelligence for drug development applications NEW ORLEANS, Aug. 17, 2026 /PRNewswire/ -- 28bio today launched CNS-3D...